GR3026702T3 - Lactones with antioxidising and hypolipidaemic activity useful in the therapy of the atherosclerosis - Google Patents

Lactones with antioxidising and hypolipidaemic activity useful in the therapy of the atherosclerosis

Info

Publication number
GR3026702T3
GR3026702T3 GR980400836T GR980400836T GR3026702T3 GR 3026702 T3 GR3026702 T3 GR 3026702T3 GR 980400836 T GR980400836 T GR 980400836T GR 980400836 T GR980400836 T GR 980400836T GR 3026702 T3 GR3026702 T3 GR 3026702T3
Authority
GR
Greece
Prior art keywords
atherosclerosis
lactones
antioxidising
therapy
lipoproteins
Prior art date
Application number
GR980400836T
Other languages
English (en)
Inventor
Goffredo Rosini
Claudia Baldazzi
Eleonora Romagnoli
Stefano Saguatti
Silvano Piani
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of GR3026702T3 publication Critical patent/GR3026702T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
GR980400836T 1994-12-21 1998-04-23 Lactones with antioxidising and hypolipidaemic activity useful in the therapy of the atherosclerosis GR3026702T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO940562A IT1274355B (it) 1994-12-21 1994-12-21 Lattoni ad attivita' antiossidante ed ipolipidemica utili nella terapia dell'aterosclerosi

Publications (1)

Publication Number Publication Date
GR3026702T3 true GR3026702T3 (en) 1998-07-31

Family

ID=11340165

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980400836T GR3026702T3 (en) 1994-12-21 1998-04-23 Lactones with antioxidising and hypolipidaemic activity useful in the therapy of the atherosclerosis

Country Status (9)

Country Link
US (1) US5608084A (el)
EP (1) EP0718295B1 (el)
JP (1) JP2820652B2 (el)
AT (1) ATE165354T1 (el)
DE (1) DE69502168T2 (el)
DK (1) DK0718295T3 (el)
ES (1) ES2115308T3 (el)
GR (1) GR3026702T3 (el)
IT (1) IT1274355B (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680340B2 (en) * 2000-08-21 2004-01-20 Merck & Co., Inc. Anti-hypercholesterolemic drug combination
DE10261067A1 (de) * 2002-12-24 2004-08-05 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Cholesterinsenkendes Mittel, enthaltend eine n-3-Fettsäure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674836A (en) * 1968-05-21 1972-07-04 Parke Davis & Co 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
US4665091A (en) * 1985-11-04 1987-05-12 Merck & Co., Inc. Macrocyclic lactone HMG-CoA reductase inhibitors
US5196447A (en) * 1991-08-08 1993-03-23 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting On Behalf Of Arizona State University Neristatin 1

Also Published As

Publication number Publication date
IT1274355B (it) 1997-07-17
DE69502168T2 (de) 1998-08-13
US5608084A (en) 1997-03-04
ES2115308T3 (es) 1998-06-16
DE69502168D1 (de) 1998-05-28
JP2820652B2 (ja) 1998-11-05
ATE165354T1 (de) 1998-05-15
EP0718295A1 (en) 1996-06-26
ITBO940562A0 (it) 1994-12-21
JPH08231535A (ja) 1996-09-10
ITBO940562A1 (it) 1996-06-21
EP0718295B1 (en) 1998-04-22
DK0718295T3 (da) 1999-01-11

Similar Documents

Publication Publication Date Title
AU4025599A (en) Compositions comprising anti-microtubule agents for treating or preventing inflammatory diseases
PL336414A1 (en) Substituted derivatives of benzopyrane for treating inflammatory states
CY1112024T1 (el) Αναστολεις υποδοχεων adp αιμοπεταλιων
CA2583037A1 (en) Pouched compositions comprising peracid
AU3664401A (en) Platelet adp receptor inhibitors
FR2789615B1 (fr) Traitement de pieces metalliques par choc laser
HK1038691B (zh) 治療眼病症的抗生素合成劑
EA200000888A1 (ru) Производные желчных кислот
ATE228015T1 (de) Intestinale absorption von nikotin für die behandlung von nikotinabhängigen zustanden
EA200100707A1 (ru) Сочетания ингибиторов транспорта желчных кислот в подвздошной кишке и производных фибриновой кислоты для сердечно-сосудистых показаний
PL367517A1 (en) Dual action antibiotics
NO20014767L (no) Celleadhesjons-inhiberende antiinflammasjon og immun- suppressive forbindelser
GR3026702T3 (en) Lactones with antioxidising and hypolipidaemic activity useful in the therapy of the atherosclerosis
ES2124327T3 (es) Derivados de sulfonamida aminometileno como inmunosupresores.
ES2108698T3 (es) Liposomas exentos de sustancias activas, para el tratamiento de aterosclerosis.
PL357498A1 (en) Synergistic combinations of an nk1
ES2189206T3 (es) Beta-alcoxiacrilatos contra la malaria.
AU6210600A (en) Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis
HK1045984A1 (en) Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives useful for the treatment of dry eye
WO1999021832A3 (en) Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders
IL154006A0 (en) Method for treating unstable angina pectoris
AU1396501A (en) Packaged portions of detergent
ATE270284T1 (de) Cholesterin esterase inhibitoren
AU2919800A (en) Bleaching of pulp with peracid as final bleaching agent
BR9914895A (pt) Composições compreendendo uma mistura de bioflavonóis